• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用癌症治疗功能评估量表评估下尿路症状对生活质量的影响。

Impact of lower urinary tract symptoms on quality of life using Functional Assessment Cancer Therapy scale.

作者信息

Batista-Miranda Jose E, Molinuevo Beatriz, Pardo Yolanda

机构信息

Urodynamics Unit, CM Teknon, Barcelona, Spain.

出版信息

Urology. 2007 Feb;69(2):285-8. doi: 10.1016/j.urology.2006.09.054.

DOI:10.1016/j.urology.2006.09.054
PMID:17320665
Abstract

OBJECTIVES

To assess the impact of lower urinary tract symptoms (LUTS) on general quality-of-life (QOL) measures in an outpatient setting.

METHODS

A total of 1546 male patients aged 51 years or older and scoring more than 11 in the International Prostate Symptom Score completed the general version of the Functional Assessment Cancer Therapy, the Benign Prostatic Hyperplasia Impact Index, and additional questions. Previous prostatic surgery and neurourologic conditions were exclusion criteria, but the use of urologic medication was not.

RESULTS

LUTS and QOL were significantly related to age, with older patients presenting with more symptoms and worse QOL. In addition, the results showed negative correlations between LUTS and QOL. The division of the severity groups according to the International Prostate Symptom Score showed that patients from the severe group reported significantly worse QOL compared with the moderate group. The 32% variance in the FACT-G was explained by the International Prostate Symptom Score items, controlling for age. Nocturia combined with incomplete bladder emptying were the strongest predictors of QOL.

CONCLUSIONS

LUTS have considerable impact on the general well-being of the patient. Combined with age, they can explain up to 30% of the variance in QOL. Nocturia and incomplete emptying are the most troublesome symptoms.

摘要

目的

评估门诊环境下下尿路症状(LUTS)对总体生活质量(QOL)指标的影响。

方法

共有1546名年龄在51岁及以上、国际前列腺症状评分超过11分的男性患者完成了癌症治疗功能评估通用版、良性前列腺增生影响指数及其他问题。既往前列腺手术史和神经泌尿疾病为排除标准,但使用泌尿药物不在此列。

结果

LUTS和QOL与年龄显著相关,年龄较大的患者症状更多,QOL更差。此外,结果显示LUTS与QOL之间呈负相关。根据国际前列腺症状评分划分严重程度组,结果显示重度组患者的QOL显著差于中度组。在控制年龄的情况下,国际前列腺症状评分项目可解释FACT-G中32%的方差。夜尿症合并膀胱排空不全是QOL最强的预测因素。

结论

LUTS对患者的总体健康状况有相当大的影响。结合年龄因素,它们可解释QOL中高达30%的方差。夜尿症和排空不全是最麻烦的症状。

相似文献

1
Impact of lower urinary tract symptoms on quality of life using Functional Assessment Cancer Therapy scale.采用癌症治疗功能评估量表评估下尿路症状对生活质量的影响。
Urology. 2007 Feb;69(2):285-8. doi: 10.1016/j.urology.2006.09.054.
2
Risk factors for lower urinary tract symptoms suggestive of benign prostatic hyperplasia in a community based population of healthy aging men: the Krimpen Study.基于社区的健康老年男性人群中提示良性前列腺增生的下尿路症状的危险因素:克林彭研究
J Urol. 2009 Feb;181(2):710-6. doi: 10.1016/j.juro.2008.10.025. Epub 2008 Dec 16.
3
Clinical impact of tamsulosin on generic and symptom-specific quality of life for benign prostatic hyperplasia patients: using international prostate symptom score and Rand Medical Outcomes Study 36-item Health Survey.坦索罗辛对良性前列腺增生症患者总体及症状特异性生活质量的临床影响:采用国际前列腺症状评分和兰德医疗结局研究36项健康调查
Int J Urol. 2006 Sep;13(9):1202-6. doi: 10.1111/j.1442-2042.2006.01594.x.
4
Association among the symptoms, quality of life and urodynamic parameters in patients with improved lower urinary tract symptoms following a transurethral resection of the prostate.经尿道前列腺切除术后下尿路症状改善患者的症状、生活质量与尿动力学参数之间的关联
Neurourol Urodyn. 2008;27(3):222-5. doi: 10.1002/nau.20466.
5
An Asian multinational prospective observational registry of patients with benign prostatic hyperplasia, with a focus on comorbidities, lower urinary tract symptoms and sexual function.一项亚洲多国针对良性前列腺增生患者的前瞻性观察性登记研究,重点关注合并症、下尿路症状和性功能。
BJU Int. 2008 Jan;101(2):197-202. doi: 10.1111/j.1464-410X.2007.07320.x. Epub 2007 Nov 13.
6
Assessment of lower urinary tract symptoms in men by international prostate symptom score and core lower urinary tract symptom score.国际前列腺症状评分和核心下尿路症状评分评估男性下尿路症状。
BJU Int. 2012 May;109(10):1512-6. doi: 10.1111/j.1464-410X.2011.10445.x. Epub 2011 Aug 26.
7
Using the ICSOoL to measure the impact of lower urinary tract symptoms on quality of life: evidence from the ICS-'BPH' Study. International Continence Society--Benign Prostatic Hyperplasia.使用国际前列腺症状评分(ICSOoL)评估下尿路症状对生活质量的影响:来自国际尿控协会-良性前列腺增生症(ICS-‘BPH’)研究的证据。国际尿控协会-良性前列腺增生症
Br J Urol. 1997 Nov;80(5):712-21.
8
Impact of surgical treatment on nocturia in men with benign prostatic obstruction.手术治疗对良性前列腺梗阻男性夜尿症的影响。
BJU Int. 2006 Oct;98(4):799-805. doi: 10.1111/j.1464-410X.2006.06380.x.
9
Urodynamic evaluation in diabetic patients with prostate enlargement and lower urinary tract symptoms.糖尿病合并前列腺增生及下尿路症状患者的尿动力学评估
Urol Int. 2008;80(4):378-82. doi: 10.1159/000132695. Epub 2008 Jun 27.
10
Visual analog scale questionnaire to assess quality of life specific to each symptom of the International Prostate Symptom Score.用于评估国际前列腺症状评分中每种症状特定生活质量的视觉模拟量表问卷。
J Urol. 2006 Aug;176(2):665-71. doi: 10.1016/j.juro.2006.03.031.

引用本文的文献

1
The Correlation Between Body Mass Index and Prostate Volume: A Retrospective Analysis of Pre and Postoperative Measurements in Prostate Cancer Patients.体重指数与前列腺体积的相关性:前列腺癌患者术前和术后测量值的回顾性分析
Prostate. 2025 Apr;85(5):433-442. doi: 10.1002/pros.24845. Epub 2024 Dec 23.
2
Urinary tract symptoms that should be improved to enhance post-operative urinary quality of life in patients treated with low-dose-rate brachytherapy for prostate cancer: An importance-performance analysis.为提高前列腺癌低剂量率近距离放射治疗患者术后泌尿生活质量应改善的尿路症状:重要性-绩效分析
J Contemp Brachytherapy. 2024 Feb;16(1):12-20. doi: 10.5114/jcb.2024.135646. Epub 2024 Feb 23.
3
Effects of a proprietary mixture of extracts from fruits and roots (WS 1541) on prostate hyperplasia and inflammation in rats and human cells.
一种水果和根部提取物的专利混合物(WS 1541)对大鼠和人类细胞前列腺增生及炎症的影响。
Front Pharmacol. 2024 Mar 15;15:1379456. doi: 10.3389/fphar.2024.1379456. eCollection 2024.
4
An evaluation of lower urinary tract symptoms in diabetic patients: a cross-sectional study.糖尿病患者下尿路症状评估:一项横断面研究。
BMC Urol. 2022 Nov 10;22(1):178. doi: 10.1186/s12894-022-01133-1.
5
Comparison of Tamsulosin and Tadalafil effects in LUTS treatment considering patients' atherosclerosis risk level.考虑患者动脉粥样硬化风险水平时坦索罗辛与他达拉非治疗下尿路症状的疗效比较。
Ann Med Surg (Lond). 2022 Jul 9;80:104137. doi: 10.1016/j.amsu.2022.104137. eCollection 2022 Aug.
6
Positive Predictive Value of Benign Prostatic Hyperplasia and Acute Urinary Retention in the Danish National Patient Registry: A Validation Study.丹麦国家患者登记处中良性前列腺增生和急性尿潴留的阳性预测值:一项验证研究
Clin Epidemiol. 2020 Nov 16;12:1281-1285. doi: 10.2147/CLEP.S278554. eCollection 2020.
7
Factors Associated With Nocturia-Related Quality of Life in Men With Lower Urinary Tract Symptoms and Treated With Tamsulosin Oral Controlled Absorption System in a Non-Interventional Study.在一项非干预性研究中,与下尿路症状男性且使用坦索罗辛口服控释系统治疗的夜尿相关生活质量相关的因素
Front Pharmacol. 2020 Jun 4;11:816. doi: 10.3389/fphar.2020.00816. eCollection 2020.
8
Determination of variability due to biological and technical variation in urinary extracellular vesicles as a crucial step in biomarker discovery studies.确定尿液细胞外囊泡中生物和技术变异所导致的变异性,作为生物标志物发现研究的关键步骤。
J Extracell Vesicles. 2019 Oct 13;8(1):1676035. doi: 10.1080/20013078.2019.1676035. eCollection 2019.
9
Prevalence and management status of urologic disease in geriatric hospitals in South Korea: A population-based analysis.韩国老年医院泌尿科疾病的流行状况和管理现状:基于人群的分析。
Investig Clin Urol. 2017 Jul;58(4):281-288. doi: 10.4111/icu.2017.58.4.281. Epub 2017 Jun 27.
10
The Best of Both Worlds: An Example Mixed Methods Approach to Understand Men's Preferences for the Treatment of Lower Urinary Tract Symptoms.两全其美:一种混合方法研究,旨在了解男性对下尿路症状治疗的偏好。
Patient. 2018 Feb;11(1):55-67. doi: 10.1007/s40271-017-0263-7.